Tarsus Pharmaceuticals, Inc. (TARS)

NASDAQ: TARS · IEX Real-Time Price · USD

27.55

-0.69 (-2.44%)

At close: Jul 2, 2024, 4:00 PM

26.97

-0.58 (-2.11%)

After-hours: Jul 2, 2024, 6:28 PM EDT

Tarsus Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-135.89	-62.09	-13.83	-26.81	-4.67	Upgrade
Depreciation & Amortization	1.42	0.79	0.61	0.25	0.07	Upgrade
Share-Based Compensation	19.83	13.46	8.46	0.84	0.02	Upgrade
Other Operating Activities	-2.85	-1.19	8.51	4.59	0.91	Upgrade
Operating Cash Flow	-117.49	-49.03	3.75	-21.14	-3.67	Upgrade
Capital Expenditures	-5.5	-0.51	-0.59	-0.46	-0.18	Upgrade
Change in Investments	146.11	-144.12	0	0	0	Upgrade
Investing Cash Flow	140.6	-144.63	-0.59	-0.46	-0.18	Upgrade
Share Issuance / Repurchase	120.18	74.94	0.32	92.04	0	Upgrade
Debt Issued / Paid	10	19.13	0	0	1.99	Upgrade
Other Financing Activities	-	-0.08	-0.3	39.73	57.46	Upgrade
Financing Cash Flow	130.18	93.99	0.02	131.77	59.45	Upgrade
Net Cash Flow	153.29	-99.67	3.18	110.18	55.6	Upgrade
Free Cash Flow	-123	-49.54	3.16	-21.59	-3.85	Upgrade
Free Cash Flow Margin	-704.96%	-191.88%	5.54%	-	-	Upgrade
Free Cash Flow Per Share	-4.19	-2.01	0.15	-3.48	-1.63	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).